This site is intended for healthcare professionals
News

Positive results from second phase III study evaluating once-daily relugolix combination therapy in women with endometriosis.- Myovant Sciences.

Read time: 1 mins
Last updated:26th Jun 2020
Published:26th Jun 2020
Condition: Pain; Endometriosis
Type: drug
Register free for full access to medthority.com